Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Authors
Popat, SKim, H
Ahn, M
Yang, J
Han, J
Hochmair, M
Lee, K
Delmonte, A
Campelo, M
Kim, D
Griesinger, F
Felip, E
Califano, Raffaele
Spira, A
Gettinger, S
Tiseo, M
Haney, J
Kerstein, D
Camidge, D
Affiliation
Medical Oncology, Royal Marsden Hospital, London, UKIssue Date
2018
Metadata
Show full item recordCitation
Popat S, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, et al. LBA58 Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. Ann Oncol. 2018;29(suppl_8):746.Journal
Annals of OncologyDOI
10.1093/annonc/mdy424.070Additional Links
https://dx.doi.org/10.1093/annonc/mdy424.070Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy424.070